L. Ratz

Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer

J. Jonkers, M. van de Ven, N. Proost, 2022, Breast Cancer Research.

EZH2 inhibition sensitizes BRCA1-deficient breast cancer cells to synthetic lethal therapy with ATM inhibitors

M. Lohuizen, J. Jonkers, N. Proost, 2021, Senologie - Zeitschrift für Mammadiagnostik und -therapie.

miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells

S. Klauck, G. Kristiansen, P. Altevogt, 2021, Cancers.

Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53.

G. Kristiansen, A. Stenzinger, M. Falkenstein, 2020, Urologic oncology.

TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cells

S. Klauck, P. Altevogt, H. Sültmann, 2017, Oncotarget.

Genome-Based Classification and Therapy of Prostate Cancer

S. Klauck, H. Sültmann, A. Angeles, 2018, Diagnostics.

A Prominent Couple : the TMPRSS2:ERG Gene Fusion in Aggressive Prostate Cancer

L. Ratz, 2017 .

Novel RNA Markers in Prostate Cancer: Functional Considerations and Clinical Translation

S. Klauck, D. Heckmann, H. Sültmann, 2014, BioMed research international.